Literature DB >> 21832244

A novel facet to consider for the effects of butyrate on its target cells. Focus on "The short-chain fatty acid butyrate is a substrate of breast cancer resistance protein".

Ravinder K Gill, Pradeep K Dudeja.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21832244      PMCID： PMC3213925          DOI： 10.1152/ajpcell.00290.2011

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN： 0363-6143            Impact factor:   4.249


× No keyword cloud information.
  29 in total

1.  Butyrate induced Caco-2 cell apoptosis is mediated via the mitochondrial pathway.

Authors:  F M Ruemmele; S Schwartz; E G Seidman; S Dionne; E Levy; M J Lentze
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

Review 2.  Short-chain fatty acid in the human colon. Relation to inflammatory bowel diseases and colon cancer.

Authors:  G D'Argenio; G Mazzacca
Journal:  Adv Exp Med Biol       Date:  1999       Impact factor: 2.622

3.  The role of short-chain fatty acids in orchestrating two types of programmed cell death in colon cancer.

Authors:  Yong Tang; Yakun Chen; Hongmei Jiang; Daotai Nie
Journal:  Autophagy       Date:  2011-02-01       Impact factor: 16.016

4.  Short-chain fatty acids regulate the enteric neurons and control gastrointestinal motility in rats.

Authors:  Rodolphe Soret; Julien Chevalier; Pierre De Coppet; Guillaume Poupeau; Pascal Derkinderen; Jean Pierre Segain; Michel Neunlist
Journal:  Gastroenterology       Date:  2010-02-10       Impact factor: 22.682

5.  Butyrate mediates Caco-2 cell apoptosis via up-regulation of pro-apoptotic BAK and inducing caspase-3 mediated cleavage of poly-(ADP-ribose) polymerase (PARP).

Authors:  F M Ruemmele; S Dionne; I Qureshi; D S Sarma; E Levy; E G Seidman
Journal:  Cell Death Differ       Date:  1999-08       Impact factor: 15.828

Review 6.  Nutrient transporters in cancer: relevance to Warburg hypothesis and beyond.

Authors:  Vadivel Ganapathy; Muthusamy Thangaraju; Puttur D Prasad
Journal:  Pharmacol Ther       Date:  2008-11-01       Impact factor: 12.310

7.  Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate.

Authors:  Ho Jung Shin; Naohiko Anzai; Atsushi Enomoto; Xin He; Do Kyung Kim; Hitoshi Endou; Yoshikatsu Kanai
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

8.  Butyrate as an effective treatment of congenital chloride diarrhea.

Authors:  Roberto Berni Canani; Gianluca Terrin; Pia Cirillo; Giuseppe Castaldo; Francesco Salvatore; Giuseppe Cardillo; Anna Coruzzo; Riccardo Troncone
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682

9.  The microbe-derived short chain fatty acid butyrate targets miRNA-dependent p21 gene expression in human colon cancer.

Authors:  Shien Hu; Tien Sy Dong; Sushila R Dalal; Feng Wu; Marc Bissonnette; John H Kwon; Eugene B Chang
Journal:  PLoS One       Date:  2011-01-20       Impact factor: 3.240

10.  Microbial induction of immunity, inflammation, and cancer.

Authors:  Julia B Greer; Stephen John O'Keefe
Journal:  Front Physiol       Date:  2011-01-26       Impact factor: 4.566
View more
  3 in total

1.  Effects of Lactobacillus acidophilus and Bifidobacterium bifidum Probiotics on the Expression of MicroRNAs 135b, 26b, 18a and 155, and Their Involving Genes in Mice Colon Cancer.

Authors:  Zahra Heydari; Mahdi Rahaie; Ali Mohammad Alizadeh; Shahram Agah; Solmaz Khalighfard; Sahar Bahmani
Journal:  Probiotics Antimicrob Proteins       Date:  2019-12       Impact factor: 4.609

2.  Sodium Butyrate Promotes Reassembly of Tight Junctions in Caco-2 Monolayers Involving Inhibition of MLCK/MLC2 Pathway and Phosphorylation of PKCβ2.

Authors:  Wei Miao; Xiujuan Wu; Kang Wang; Wenjing Wang; Yumei Wang; Zhigang Li; Jingjing Liu; Li Li; Luying Peng
Journal:  Int J Mol Sci       Date:  2016-10-10       Impact factor: 5.923

3.  ZEB1 Mediates Drug Resistance and EMT in p300-Deficient CRC.

Authors:  Darina Lazarova; Michael Bordonaro
Journal:  J Cancer       Date:  2017-05-12       Impact factor: 4.207
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.